Release Date: 26/08/14 08:56 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 956.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%